AOD-9604 vs SLU-PP-332

Name: AOD-9604 vs SLU-PP-332
Published: 2026-10-24

Updated Oct 24, 20268 sources

Key differences

1AOD-9604 is a growth-hormone fragment with human Phase 2 history. SLU-PP-332 is an ERR agonist with mouse data only.
2Different targets: fat-cell lipolysis for AOD-9604, mitochondrial and endurance genes for SLU-PP-332.

Facts from each record, in the same words as their own pages.

AOD-9604 and SLU-PP-332 side by side
	AOD-9604	SLU-PP-332
Category	Weight loss	Weight loss, Longevity
Evidence	Limited human data	Animal data only
FDA status	Not FDA approvedRegulatory	Not FDA approvedRegulatory
WADA	Prohibited	Not confirmed
Half-life	About 3 minutes after an IV bolus in pigs and about 4 minutes in rat blood in vitro. No human subcutaneous data.Clinical study	No half-life published in any species. After a 30 mg/kg injection in mice it was still measurable in plasma and muscle 2 to 6 hours later.Clinical study One guide states about 1.5 hours in mice, without citing a study.Competitor guide
Routes	Oral, Subcutaneous injection	Subcutaneous injection, Oral
Forms	Not reported	Vial (powder), Tablet, Capsule, Oral solution
Reported doses	0.25 to 30 mg (oral) 250 to 500 mcg (subcutaneous injection) 1 to 2 mg (subcutaneous injection)	250 to 1,500 mcg (subcutaneous injection) 1 to 10 mg (subcutaneous injection) 5 to 100 mg (oral)
Most cited frequency	Once daily	Once daily; 500 mcg a day is a common example
Vial sizes	2 mg, 5 mg, 10 mgCompetitor guide	5 mg, 10 mg, 20 mgVendor guide
Mixed vial keeps	Keep at 2 to 8 °C, away from light, and do not freeze and thaw.Community-reported	Fridge at 2 to 8 °C, protected from light.Competitor guide
Protocols on file	12	7

Doses shown are what sources report, labelled by origin. Not medical advice.

8 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.